Ab­cam founder Jonathan Mil­ner op­pos­es Dana­her buy­out; First Wave tries to find new life in Sanofi drug

Ab­cam’s founder Jonathan Mil­ner plans to vote against Dana­her’s $5.7 bil­lion ac­qui­si­tion of the com­pa­ny, he an­nounced Thurs­day.

Mil­ner owns 6.14% of Ab­cam. He found­ed the com­pa­ny in 1998 and re­mained its CEO un­til 2014. Mil­ner be­lieves the deal “sub­stan­tial­ly un­der­val­ues Ab­cam,” ac­cord­ing to the press state­ment.

Mil­ner al­so plans to re­quest that the board of di­rec­tors con­vene a gen­er­al meet­ing to dis­cuss re­plac­ing Ab­cam’s board, CEO, CFO and chair­man. — Lei Lei Wu

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER